Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses
- 17 July 2003
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (16) , 9458-9463
Abstract
The concern about bioterrorism with smallpox has raised the possibility of widespread vaccination, but the greater prevalence of immunocompromised individuals today requires a safer vaccine, and the mechanisms of protection are not well understood. Here we show that, at sufficient doses, the protection provided by both modified vaccinia Ankara and NYVAC replication-deficient vaccinia viruses, safe in immunocompromised animals, was equivalent to that of the licensed Wyeth vaccine strain against a pathogenic vaccinia virus intranasal challenge of mice. A similar variety and pattern of immune responses were involved in protection induced by modified vaccinia Ankara and Wyeth viruses. For both, antibody was essential to protect against disease, whereas neither effector CD4+nor CD8+T cells were necessary or sufficient. However, in the absence of antibody, T cells were necessary and sufficient for survival and recovery. Also, T cells played a greater role in control of sublethal infection in unimmunized animals. These properties, shared with the existing smallpox vaccine, provide a basis for further evaluation of these replication-deficient vaccinia viruses as safer vaccines against smallpox or against complications from vaccinia virus.Keywords
This publication has 48 references indexed in Scilit:
- Modeling a Safer Smallpox Vaccination Regimen, for Human Immunodeficiency Virus Type 1–Infected Patients, in Immunocompromised MacaquesThe Journal of Infectious Diseases, 2003
- Dose-Related Effects of Smallpox VaccineNew England Journal of Medicine, 2002
- Developing New Smallpox VaccinesEmerging Infectious Diseases, 2001
- Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + LymphocytesScience, 1999
- Immunoglobulin E Production in the Absence of Interleukin-4-Secreting CD1-Dependent CellsScience, 1997
- Successful T cell priming in B cell-deficient mice.Journal of Experimental Medicine, 1995
- Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccinesVaccine, 1994
- Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory routeJournal of General Virology, 1990
- T Cell Response to Viral and Bacterial InfectionImmunological Reviews, 1974
- IMMUNE RESPONSE TO CHEMICALLY MODIFIED FLAGELLINJournal of Experimental Medicine, 1972